ResearcherJohns Hopkins UniversityNo recent work listed
Agnieszka A. Rucki
Matched on OpenAlex author ID A5111625216. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 4 papers
Papers 7
- Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-16-1383↗
- Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. Co-author DOI 10.1158/1535-7163.mct-16-0452↗
- Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. Co-author DOI 10.18632/oncotarget.22433↗
- Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma. First author DOI 10.21037/jgo.2016.10.02↗
- Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation. Co-author DOI 10.1158/0008-5472.can-15-3264↗
- Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. First author DOI 10.1126/scisignal.aaa5823↗
- Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies. Co-author DOI 10.3748/wjg.v20.i9.2237↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei Zheng · 6 shared papers, 2015–2017 · strength 0.40
- Paper Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma. DOI 10.21037/jgo.2016.10.02↗
- Paper Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. DOI 10.18632/oncotarget.22433↗
- Paper Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. DOI 10.1158/1535-7163.mct-16-0452↗
- Elizabeth M. Jaffee · 5 shared papers, 2015–2017 · strength 0.30
- Paper Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. DOI 10.18632/oncotarget.22433↗
- Paper Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. DOI 10.1158/1535-7163.mct-16-0452↗
- Paper Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer. DOI 10.1158/0008-5472.can-16-1383↗
- Qian Xiao · 4 shared papers, 2015–2017 · strength 0.22
- Paper Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. DOI 10.1158/1535-7163.mct-16-0452↗
- Paper Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer. DOI 10.1158/0008-5472.can-16-1383↗
- Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
- Kelly Foley · 3 shared papers, 2015–2017 · strength 0.18
- Paper Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. DOI 10.18632/oncotarget.22433↗
- Paper Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer. DOI 10.1158/0008-5472.can-16-1383↗
- Paper Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. DOI 10.1126/scisignal.aaa5823↗
- Xu Che · 2 shared papers, 2017 · strength 0.17
- Robert A. Anders · 3 shared papers, 2015–2017 · strength 0.16
- Paper Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. DOI 10.1158/1535-7163.mct-16-0452↗
- Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
- Paper Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. DOI 10.1126/scisignal.aaa5823↗
- Adrian Gerard Murphy · 2 shared papers, 2016–2017 · strength 0.13
- Annie A. Wu · 2 shared papers, 2015–2017 · strength 0.10
- Ying Zeng · 1 shared paper, 2017 · strength 0.10
- Tao Xia · 1 shared paper, 2017 · strength 0.08
- Stephen T. Muth · 1 shared paper, 2017 · strength 0.07
- Bülent Salman · 1 shared paper, 2016 · strength 0.05
- Kenji Fujiwara · 1 shared paper, 2016 · strength 0.05
- Christopher L. Wolfgang · 1 shared paper, 2016 · strength 0.05
- Anirban Maitra · 1 shared paper, 2015 · strength 0.04
- Christine A. Iacobuzio–Donahue · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.